Down 34% Last Month, Should You Buy BioNTech Stock For Near …

Oct 20, 2021 · (1% event probability) BioNTech stock declined -34% over the last twenty-one trading days (about one month), compared to the broader market (S&P500) which declined by …

34%
OFF

Down 34% Last Month, Should You Buy BioNTech Stock For Near …

2 weeks from now

Oct 20, 2021 · (1% event probability) BioNTech stock declined -34% over the last twenty-one trading days (about one month), compared to the broader market (S&P500) which declined by …

nasdaq.com

34%
OFF

Down 34% Last Month, Should You Buy BioNTech Stock For Near …

2 weeks from now

Oct 19, 2021 · BioNTech stock rose 0.7% over a five day trading period ending 10/15/2021, compared to the broader market (S&P500) which rose by 1.8%; A change of 0.7% or more …

forbes.com

34%
OFF

Down 34% Last Month, Should You Buy BioNTech Stock For Near …

2 weeks from now

Oct 18, 2021 · (56% event probability) BioNTech stock rose 0.7% over a five day trading period ending 10/15/2021, compared to the broader market (S&P500) which rose by 1.8%; A change …

trefis.com

$76.53
OFF

BioNTech SE (NASDAQ:BNTX) Receives Average Recommendation …

2 weeks from now

12 hours ago · BioNTech has a 12 month low of $76.53 and a 12 month high of $131.49. The stock has a 50-day simple moving average of $114.42 and a 200 day simple moving average …

marketbeat.com

04%
OFF

Breaking Down BioNTech: 16 Analysts Share Their Views

2 weeks from now

Nov 6, 2024 · Revenue Growth: Over the 3 months period, BioNTech showcased positive performance, achieving a revenue growth rate of 39.04% as of 30 September, 2024. This …

nasdaq.com

3%
OFF

BioNTech Stock Nears A Sell Signal After Cutting Outlook Despite ...

2 weeks from now

Nov 4, 2024 · On today's stock market, BioNTech stock fell 2.3% to close at 108.97. Shares broke out of a lengthy consolidation with a buy point at 114.69 on Sept. 13, MarketSurge chart …

investors.com

$131.75
OFF

8 Analysts Have This To Say About BioNTech | Markets Insider

2 weeks from now

Oct 17, 2023 · According to 8 analyst offering 12-month price targets in the last 3 months, BioNTech has an average price target of $131.75 with a high of $180.00 and a low of $110.00.

businessinsider.com

$5.39
OFF

Biontech Se Sponsored Adr Stock Price Forecast. Should You Buy …

2 weeks from now

Jan 6, 2025 · This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $5.39 between high …

stockinvest.us

$127.53
OFF

What Analysts Are Saying About BioNTech Stock | Nasdaq

2 weeks from now

Nov 8, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $127.53, a high estimate of $150.00, and a low …

nasdaq.com

34%
OFF

What's Happening With BioNTech Stock? - Nasdaq

2 weeks from now

Jan 21, 2022 · Below you’ll find our previous coverage of BioNTech stock where you can track our view over time. [10/18/2021] Down 34% Last Month, Should You Buy BioNTech Stock For …

nasdaq.com

74%
OFF

Is It Too Late To Buy BioNTech Stock? | The Motley Fool

2 weeks from now

Aug 28, 2021 · That's why it's important to consider a stock like BioNTech (BNTX-0.74%). Sure, the stock has climbed 962% since the beginning of last year. But a lot has happened since. …

fool.com

8%
OFF

BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue To Soar?

2 weeks from now

Sep 13, 2024 · BioNTech SE Sponsored ADR (BNTX) shares soared 5.8% in the last trading session to close at $105. The move was backed by solid volume with far more shares …

nasdaq.com

40%
OFF

Truist Rates BioNTech A Buy, Citing 40% Upside ... - Investing.com

2 weeks from now

6 days ago · 邏 Just 1 week into 2025: These 7 AI-picked stocks are up 9%+ each Unlock Stocks Get 100% ad-free experience Truist rates BioNTech a Buy, citing 40% upside potential with …

investing.com

94%
OFF

Moderna Stock Has Lost 94% Of Its Value Over Four Years. Is It A …

2 weeks from now

1 day ago · Moderna stock peaked at 497.49 in August 2021, at the height of the Covid pandemic. Since then, the stock has fallen precipitously, down 94% over the past four years. Is Moderna …

investors.com

31%
OFF

What’s Happening With BioNTech Stock? - Forbes

2 weeks from now

Jan 20, 2022 · BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming …

forbes.com

FAQs about Down 34% Last Month, Should You Buy BioNTech Stock For Near … Coupon?

Is it too late to buy biontech stock?

The biggest reason why it might be too late to buy BioNTech stock is that the market may have already fully and accurately accounted for its expected vaccine income over the next few years in its stock price. ...

Should you buy biontech (bntx) now?

In short, winners keep on winning. That's why it's important to consider a stock like BioNTech ( BNTX -1.01%). Sure, the stock has climbed 962% since the beginning of last year. But a lot has happened since. The company's future might be even brighter than its recent past. If so, there could be a lot of gains left for shareholders. ...

Does biontech stock have a chance of a rise?

According to the Trefis Machine learning engine, which analyzes historical stock price movements in the stock, BNTX has a 57% chance of a rise over the next month, after rising by about 21% over the last 21 trading days. See our analysis BioNTech Stock Chances Of Rise for more details. So what’s the fundamental picture like for BioNTech? ...

What is the average price target for biontech (bntx)?

According to the 14 analysts' twelve-month price targets for BioNTech, the average price target is $135.54. The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. The average price target represents a forecasted upside of 22.24% from the current price of $110.88. ...

Why is biontech stock a sell-off?

The sell-off comes despite the recent surge in daily U.S. Covid-19 cases to over 800,000, driven by the spread of the highly infectious omicron virus variant, and a growing market for booster doses, with the U.S. CDC recommending third doses for younger age groups. So why exactly is BioNTech stock trending lower? ...

Is biontech se a good investment?

Despite recent challenges in revenue and earnings, BioNTech SE's market capitalization of $29.37 billion and consistent investment from institutional investors highlight long-term growth potential. ...